September 20, 2017 3:25 AM ET

Pharmaceuticals

Company Overview of HUYA Bioscience International, LLC

Company Overview

HUYA Bioscience International, LLC identifies and licenses pre-clinical and clinical stage compounds in China. It engages in accelerating the development of biopharmaceutical product opportunities originating in China. The company offers HBI-8000, a histone deacetylases inhibitors for cancer; HBI-3000, a multi-ion channel blocker for the treatment of arrhythmia; and HBI-3802, a small molecule for improving heart function, as well as stimulates cardiac stem cell differentiation into functional cardiomyocytes, and replaces and remodels dead myocardium with new functional tissues. HUYA Bioscience International, LLC has strategic alliances with China Wuqing Development Area and Korea Drug Develo...

12531 High Bluff Drive

Suite 138

San Diego, CA 92130

United States

Founded in 2004

Phone:

858-798-8800

Fax:

858-798-8888

Key Executives for HUYA Bioscience International, LLC

Founder and Executive Chairman
Age: 53
Vice President of Finance
Senior Vice President of Operations
Chief Technology Officer and Chief Operating Officer of Asia
Head of Therapeutics China
Compensation as of Fiscal Year 2017.

HUYA Bioscience International, LLC Key Developments

HUYA Bioscience International Establishes Strategic Partnership with Suzhou BioTOP

HUYA Bioscience International announced a strategic collaboration agreement with Suzhou BioTOP Technical Service Co. Ltd. The collaboration will focus on promoting the development of biomedical innovations from companies and research organizations in Suzhou BioBay that help to meet the increasing demand to fill global pharmaceutical pipelines. The agreement combines the expertise of both HUYA and BioTOP to promote biomedical innovations with global market potential in the Yangtze River Delta region. Local pharmaceutical companies and research organizations in BioBay will have opportunities to access HUYA's international pharmaceutical knowledge and network resources, as well as the HUYA team's expertise in drug development and commercialization. In return, HUYA will have priority to evaluate certain research and development opportunities of these entities, and potentially co-develop them for global markets in the future. This partnership is an exciting strategic step given the knowledge sharing and synergies it will create between HUYA and BioTOP.

HUYA Bioscience International and CAS Innovation and Investment Company Establish Strategic Collaboration

HUYA Bioscience International announced a strategic collaboration agreement with the Chinese Academy of Sciences Innovation and Investment Company. The collaboration will focus on developing and commercializing biomedical innovations discovered by leading scientists at CAS to meet the medical needs of patients around the world. Under this agreement, HUYA and CAS Innovation will collaborate to develop novel drugs discovered by CAS scientists. Biotech and pharmaceutical R&D organizations within the CAS Innovation platform will have access to HUYA's international pharmaceutical expertise and networks as well as support from HUYA's global team of experts. In turn, HUYA will have priority to evaluate certain research and development projects conducted by these CAS organizations and secure partnerships to further develop and commercialize these candidate therapeutics for global markets.

HUYA Bioscience International, LLC Presents at BIO Europe 2016 Conference, Nov-08-2016 03:45 PM

HUYA Bioscience International, LLC Presents at BIO Europe 2016 Conference, Nov-08-2016 03:45 PM. Venue: KoelnMesse - Congress Center North, Cologne, Germany.

Similar Private Companies By Industry

Company Name Region
1st Order Pharmaceuticals, Inc. United States
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Tax Management Inc United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact HUYA Bioscience International, LLC, please visit www.huyabio.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.